æ§æ Œã¯åïŒäººçãæ¯é ããäœå äŒéç©è³ª
ã¯ããã«ïŒæ·±å€ã®ã©ãŒã¡ã³ã¯ãããªãã®æå¿ã匱ãããã§ã¯ãããŸãã
ã©ãããããããŒã§ãã
ãææ¥ããã¯æ©èµ·ãããŠæ£æ©ãããïŒããšèªã£ãã¯ããªã®ã«ãç¿æã«ã¯åžå£ã®éåã«å®æããã
ãããã¯ãæ·±å€ã®ã³ã³ããã§ãããã ãã¯âŠâŠããšæã«åã£ãã«ãã麺ãåããªãããççãªèªå·±å«æªã«é¥ãã
ããããã¯ããããŒã®æ¥åžžã§ã¯ãããŸããâŠ
æèšããŸãã
ãããªãã®ã¯ããªãã®æ§æ Œã®åé¡ã§ããæ ¹æ§ã®æ¬ åŠã§ããããŸããã
ãäœå
ã®ã«ã¯ãã«ãã©ã³ã¹ãã®ä¹±ããããããªãã®ã§ãïŒ
äžã®äžã§ã¯ãæåã¯åŒ·ãæå¿ããçãŸããããªããŠèšãããŸãããææãæããªã倧ããªååšãäœå
ã«ã¯ãããŸãã
ç§ãã¡ã®ææ
ãéäžåã飿¬²ãããã«ã¯ã幞ãã ãªããšæããç¬éãŸã§ã人çã®èµãæ¡ã£ãŠããã®ã¯è³ã®åžä»€ã§ã¯ãªããè¡æ¶²ãæµãã埮éãªååŠç©è³ªââããã«ã¢ã³ããªã®ã§ãã
ãã®èšäºãèªã¿çµããé ãããªãã¯èªåã責ããã®ããããèªåã®äœããæ»ç¥ãã¹ãç²Ÿå¯æ©æ¢°ããšããŠæãããæããããã«ãªãã¯ãã§ãã
ãããããªãã®äœå
ã§24æéäŒãŸãåããç¥ãããããçã®æ¯é
è
ãã®æ£äœãæŽããŠãããŸãããã
第1ç« ïŒè³ãä»ããªããè£ã®è¶ é«éãããã¯ãŒã¯ã
ç§ãã¡ã¯ãç¥çµããããäœã®æ å ±äŒéã®ã¡ã€ã³ã·ã¹ãã ã ãšæã£ãŠããŸãããå®ã¯ãã«ã¢ã³ã®æ¹ããçåœã®æŽå²ã«ãããŠã¯å§åçã«å€ãããã€åŒ·åãªã倧å 茩ãã§ãã
1.1 ãå ãã¡ã€ããŒãã®ç¥çµãšãå šåœæŸéãã®ãã«ã¢ã³
ç¥çµäŒéãç¹å®ã®å Žæãžç¬æã«ä¿¡å·ãéããå ãã¡ã€ããŒãã ãšãããããã«ã¢ã³ã¯è¡æ¶²ãšããå·ã«ã¡ãã»ãŒãžãæµããã©ãžãªã®å šåœæŸéãã§ãã
å±ããŸã§ã«æ°ç§ããæ°åã®ã¿ã€ã ã©ã°ããããŸãããäžåºŠæŸæµãããã°å šèº«ã®çްèãžäžæã«ããã€æç¶çã«åœ±é¿ãäžããŸãã
ããªããããªããšãªã仿¥ã¯æ°åãä¹ããªãããšæããæãããã¯äœå ã®æŸéå±ããåæ»ã¢ãŒããã®ä¿¡å·ãå šçŽ°èã«æµãç¶ããŠããç¶æ ãªã®ãããããŸããã
1.2 ãéµãšéµç©Žããäœã粟å¯ãªããºã«
ãã«ã¢ã³ã¯è¡æ¶²ã«ä¹ã£ãŠå šèº«ãå·¡ããŸãããã©ã®çްèã§ãåæã«äœçšããããã§ã¯ãããŸããã
ããããã®ãã«ã¢ã³ã«ã¯ãç¹å®ã®ãå容äœïŒã¬ã»ãã¿ãŒïŒããšããéµç©ŽãååšããŸãã
ãã®ãéµãšéµç©ŽããåèŽããç¬éã现èã®ã¹ã€ããããªã³ã«ãªããŸãã
ãã®ä»çµã¿ãããããããã埮éãªç©è³ªã§ãã³ãã€ã³ãã«ã巚倧ãªçåœæŽ»åã®å€åãèµ·ãããã®ã§ãã
1.3 è³ã®ãªãæ€ç©ãããããã«ã¢ã³ã§äŒè©±ãã
é©ãã¹ãããšã«ãè³ãæããªãæ€ç©ããã«ã¢ã³ïŒæ€ç©ãã«ã¢ã³ïŒã䜿ã£ãŠæé·ãéè±ãã³ã³ãããŒã«ããŠããŸãã
ã€ãŸãããã«ã¢ã³ãšã¯ãçåœãçããããã®åºæ¬ã·ã¹ãã ããã®ãã®ã
ç§ãã¡ããå¿ããšåŒãã§ããçŸè±¡ã®æ£äœããå®ã¯ãã®å€ªå€ããç¶ãååŠåå¿ã®ã¯ã»ãç©ã¿éãªã£ããã®ãšããèŠæ¹ãã§ããŸãã
第2ç« ïŒ50mããŒã«ã«ãè³ããäžæ¯ãã®å¥è·¡
ãã«ã¢ã³ã®äžçãçè§£ããäžã§æãéèŠãªã®ã¯ããã®ãå§åçãªå°ãªãããšã絶倧ãªåœ±é¿åãã®ã®ã£ãããç¥ãããšã§ãã
2.1 æ³åãçµ¶ãããè¶ åŸ®éãã®æ¯é
ãã«ã¢ã³ãè¡æ¶²äžã«ã©ããããå«ãŸããŠããããæ³åã§ããŸããïŒ
ãã®æ¿åºŠã¯ãäŸãããªãã50mããŒã«ãã£ã±ãã«åŒµã£ãæ°Žã«ãè³ããäžæ¯åïŒçŽ0.1gïŒã®ç©è³ªã溶ããããçšåºŠã§ãã
ãã®æž¬å®ããããšããå°é£ãªã»ã©ã®åŸ®éããããªãã®èº«é·ã䌞ã°ããèæãäžããæã«ã¯äººçãå·Šå³ããã»ã©ã®ãããæ°ããçµãåºãæºãšãªãã®ã§ãã
2.2 ãã£ãŒãããã¯ãšããåã®ãèªåãã¬ãŒãã
ãã«ã¢ã³ã¯åºãã£ã±ãªãã«ã¯ãªããŸããã
äŸãã°ããããã«ã¢ã³ãå¢ãããããšãè³ã®èŠåºäžéšããããååã ããšæ€ç¥ããåæ³ãæ¢ããæä»€ãåºããŸãã
ãã®ç²Ÿå¯ãªãã£ãŒãããã¯ã»ã«ãŒãããããç§ãã¡ãæèãããšãå¥åº·ãç¶æã§ãããèªåæçžŠã·ã¹ãã ïŒãã¡ãªã¹ã¿ã·ã¹ïŒãã®æ£äœã§ãã
2.3 ææ°ç§åŠïŒ32èåšãå¥ã§ããå šèº«ãªãŒã±ã¹ãã©ã
2026å¹Žã®ææ°ç ç©¶ïŒMolecular CellèªïŒã§ã¯ãå šèº«32ã®èåšãäœå æèšã®ãªãºã ã«åãããŠãã«ã¢ã³ãã¿ã³ãã¯è³ªãç·»å¯ã«å€åãããŠããããšãè§£æãããŸããã
ããªãã®äœã¯ãããªããå¯ãŠããéãã1äžçš®é¡ä»¥äžã®ã¡ãã»ãŒãžç©è³ªã飿ºããææ¥ãžã®ããã©ãŒãã³ã¹ãæŽãããè¶
巚倧ãããžã§ã¯ãããéè¡ããŠããã®ã§ãã
第3ç« ïŒäœå ãåããã3ã€ã®äž»èŠãããŒãžã£ãŒã
ããã§ãããªãã®äººçãè£ã§æ¯ãã代衚çãªãã«ã¢ã³ãã¡ã玹ä»ããŸãã
ç¹ã«ãç§ãã¡ã®æ°åãå·Šå³ããã幞ãé¢é£ãã®ã¡ã³ããŒã«ã¯æ³šç®ã§ãã
3.1 代è¬ãšãšãã«ã®ãŒã®éçªãã€ã³ã¹ãªã³ã
èµèããåºããå¯äžã®è¡ç³å€ãäžããããŒããŒã§ãã
é£ã¹ããã®ããšãã«ã®ãŒã«å€ãã现èãžå±ãã圹å²ãæ ããŸãã
çŸä»£äººã¯åœŒãåããããïŒç³è³ªã®æãããïŒã§ã圌ããããç¡çïŒããšã¹ãã©ã€ããèµ·ããã®ãç³å°¿ç ã®å§ãŸãã
圌ãããã«äŒãŸãããããã¢ã³ããšã€ãžã³ã°ã®éµãšãªããŸãã
3.2 屿©ãšèŠéã®èŠå ±åšãã¢ãã¬ããªã³ãšã³ã«ããŸãŒã«ã
ãæŠãããéããããã®ã¹ã€ãããå ¥ããã®ãã¢ãã¬ããªã³ã
ãããé·æçã«ãµããŒãããã®ããã¹ãã¬ã¹ãã«ã¢ã³ããšåŒã°ããã³ã«ããŸãŒã«ã§ãã
ã©ã¡ããçåã«äžå¯æ¬ ã§ãããçŸä»£ã®ã¹ãã¬ã¹ç€ŸäŒã§ã¯åœŒãã24æéèŠå ±ã鳎ããç¶ããŠãããããç§ãã¡ã®å¿ã¯çŒãéåã®ããã«ç²ãæãŠãŠããŸãã®ã§ãã
3.3 å¿ã圩ãã幞ãã®äžé士ã
次åã®ããŒãã§ããããŸããã代衚çãªã幞ãé¢é£ãã ãã¯å€ããŸããã
* ã»ãããã³ïŒå¿ã®å®å®ãåžããææ®è
ããæ¥å
ãæµŽã³ããšåæ³ãããææ
ã®æŽèµ°ãæããŸãã
* ãªãã·ãã·ã³ïŒèª°ããšè§Šãåããšåºããçµã®ç©è³ªããäžå®ãæ¶ãå»ãéæ³ã®æ¶²äœã§ãã
* ããŒããã³ïŒãå¿«æããšãããæ°ãã®æºæ³ãäœããéæããæã«æå€§åãããŸãã
ãããäžã€ã®ãã©ã³ã¹ãæŽã£ãç¶æ
ããããç§ãã¡ãã幞çŠããšåŒã¶ç¶æ
ã®ç©ççãªæ£äœã§ãã
ãããã«ïŒããªãã¯ãããªãã®äœã®ãåçµå¶è ãã«ãªãã
ç§ãã¡ã¯ãèªåã®äœãæã®ãŸãŸã«æãããç¬è£è ãã§ã¯ãããŸããã
ãããã100人以äžã®åæ§è±ããªåŸæ¥å¡ïŒãã«ã¢ã³ïŒãæ±ãããçµå¶è ãã«è¿ãååšã§ãã
圌ãã«ç¡çãªæ®æ¥ããããã°ãã¹ãã©ã€ãïŒç æ°ããã€ïŒãèµ·ããŸãã
éã«ã圌ããåããããç°å¢ãæŽããã°ãããªãã®äººçã¯é©ãã»ã©è»œããã«ã幞çŠã«æºã¡ããã®ãžãšå€ããå§ããŸãã
ãã«ã¢ã³ãšãããç®ã«èŠããªã糞ããæèããããšã§ãããªãã®äžçã®èŠãæ¹ã¯ä»æ¥ããå€ããã¯ãã§ãã
仿¥ããã§ããããšïŒèªåã®ææ ã«ããã«ã¢ã³åããä»®ã§ã€ããŠã¿ã
ã€ã©ã€ã©ããããããã¢ãã¬ããªã³ãèŠå ±ã鳎ãããŠããªãã誰ãã«åªããããããªã£ããããªãã·ãã·ã³ãå·¡ã£ãŠããªããšãææ ãç©è³ªã®ååã§åŒãã§ã¿ãŠãã ããã
ããã ãã§ãè³ãšäœã®éã«ãå·éãªè·é¢æããçãŸããææ
ã«æ¯ãåãããªãèªåã«æ°ã¥ãã¯ãã§ãã
ããŠãä»ãã®ç¬éãããªãã®äœå
ã§ã¯ã©ã®ãã«ã¢ã³ãäž»å°æš©ãæ¡ã£ãŠããŸããïŒ
ãåŒçšå ã»åèæç®ã
* Molecular Cell (2026/01/10): "Mouse Circadian Proteome Atlas by next-generation deep proteome analysis" (å
šèº«32èåšã®ãã«ã¢ã³åæ
ãç¶²çŸ
ããææ°è§£æ).
* The Lancet (2026/01/15): "Incretin hormones and multi-organ protection: 2026 Lancet Review" (ææ°ã®ãã«ã¢ã³å»åŠç·èª¬).
* National Institute of General Medical Sciences (NIGMS): Hormones: The Body's Chemical Messengers (Updated 2025).
* æ¥æ¬å
åæ³åŠäŒ: ããã«ã¢ã³ã®çš®é¡ãšåãïŒäžè¬åã解説ïŒã2024å¹ŽæŽæ°å.
ãããªãšæã£ããå¿æŽãããïŒ
ãã€ãèšäºãèªãã§ããã ãããããšãããããŸãïŒããã ãããµããŒãã¯ãå·ç掻åã®ç¶æããããè¯ãã³ã³ãã³ãããå±ãããããã®åæè²»ã»è³æä»£ãšããŠå€§åã«æŽ»çšãããŠããã ããŸããããå
容ãå°ãã§ãã圹ã«ç«ãŠãŸããããæž©ããå¿æŽãããã ããŸããšå¹žãã§ãïŒ